LINDEN ADVISORS LP - IRONWOOD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$8,011,000
-25.7%
7,769,000
-24.3%
0.10%
-44.6%
Q2 2020$10,786,000
+0.4%
10,269,0000.0%0.18%
-8.4%
Q1 2020$10,744,000
-10.6%
10,269,0000.0%0.19%
+34.5%
Q4 2019$12,015,000
+91.0%
10,269,000
+63.8%
0.14%
+67.1%
Q3 2019$6,290,000
-18.2%
6,269,000
-12.5%
0.08%
-27.4%
Q2 2019$7,686,000
+27.8%
7,167,000
+31.4%
0.12%
-15.2%
Q1 2019$6,016,000
-24.3%
5,456,000
-35.5%
0.14%
-37.8%
Q4 2018$7,948,000
-88.8%
8,456,000
-84.5%
0.22%
-89.7%
Q3 2018$70,771,000
-27.5%
54,456,000
-25.2%
2.15%
-28.4%
Q2 2018$97,579,000
-30.7%
72,821,000
-39.0%
3.00%
-10.1%
Q1 2018$140,908,000
+14.4%
119,321,000
+12.7%
3.34%
-8.2%
Q4 2017$123,181,000
+24.4%
105,881,000
+27.3%
3.64%
+3.6%
Q3 2017$99,022,000
+20.7%
83,156,000
+36.0%
3.51%
+1.7%
Q2 2017$82,021,000
+15.5%
61,156,000
+7.5%
3.46%
+31.0%
Q1 2017$71,008,000
+27.5%
56,915,000
+17.5%
2.64%
+21.5%
Q4 2016$55,685,000
+16.7%
48,427,000
+21.3%
2.17%
-0.4%
Q3 2016$47,710,000
+98.1%
39,927,000
+71.6%
2.18%
+106.6%
Q2 2016$24,084,00023,267,0001.06%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
K2 PRINCIPAL FUND, L.P. 9,000$9,332,0000.80%
DeepCurrents Investment Group LLC 13,031,000$13,256,0000.41%
WOLVERINE ASSET MANAGEMENT LLC 40,592,000$41,217,0000.40%
CSS LLC/IL 10,119,000$10,159,0000.37%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$10,116,0000.20%
HBK INVESTMENTS L P 14,616,000$14,753,0000.06%
Walleye Capital LLC 2,000$2,040,0000.06%
PALISADE CAPITAL MANAGEMENT, LP 2,054,000$2,092,0000.05%
Verition Fund Management LLC 3,789,000$3,865,0000.05%
OAKTREE CAPITAL MANAGEMENT LP 818,000$834,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders